📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Pathogenic mutation of ALK2 inhibits induced pluripotent stem cell reprogramming and maintenance: mechanisms of reprogramming and strategy for drug identification. (2012)

First Author: Hamasaki M
Attributed to:  The Wales Institute of Social and Economic Research, Data and Methods (WISERD) funded by ESRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/stem.1221

PubMed Identifier: 22949078

Publication URI: http://europepmc.org/abstract/MED/22949078

Type: Journal Article/Review

Volume: 30

Parent Publication: Stem cells (Dayton, Ohio)

Issue: 11

ISSN: 1066-5099